Imed Infinity Medical-Limited Partnership
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. Imed Infinity Medical-Limited Partnership was incorporated in 2020 and is based in Tel Aviv, Israel.
Imed Infinity Medical-Limited Partnership (IMED) - Total Assets
Latest total assets as of June 2025: ILA8.60 Million ILA
Based on the latest financial reports, Imed Infinity Medical-Limited Partnership (IMED) holds total assets worth ILA8.60 Million ILA as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Imed Infinity Medical-Limited Partnership - Total Assets Trend (2020–2024)
This chart illustrates how Imed Infinity Medical-Limited Partnership’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Imed Infinity Medical-Limited Partnership - Asset Composition Analysis
Current Asset Composition (December 2024)
Imed Infinity Medical-Limited Partnership's total assets of ILA8.60 Million consist of 11.7% current assets and 88.3% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 11.6% |
| Accounts Receivable | ILA0.00 | 0.0% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Imed Infinity Medical-Limited Partnership's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Imed Infinity Medical-Limited Partnership's current assets represent 11.7% of total assets in 2024, a decrease from 68.0% in 2020.
- Cash Position: Cash and equivalents constituted 11.6% of total assets in 2024, down from 67.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Imed Infinity Medical-Limited Partnership Competitors by Total Assets
Key competitors of Imed Infinity Medical-Limited Partnership based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Imed Infinity Medical-Limited Partnership - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Imed Infinity Medical-Limited Partnership generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Imed Infinity Medical-Limited Partnership is currently not profitable relative to its asset base.
Imed Infinity Medical-Limited Partnership - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 23.81 | 9.07 | 72.48 |
| Quick Ratio | 23.81 | 9.07 | 72.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA3.76 Million | ILA 1.06 Million | ILA 7.86 Million |
Imed Infinity Medical-Limited Partnership - Advanced Valuation Insights
This section examines the relationship between Imed Infinity Medical-Limited Partnership's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -7.3% |
| Total Assets | ILA7.65 Million |
| Market Capitalization | $12.22K USD |
Valuation Analysis
Below Book Valuation: The market values Imed Infinity Medical-Limited Partnership's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Imed Infinity Medical-Limited Partnership's assets decreased by 7.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Imed Infinity Medical-Limited Partnership (2020–2024)
The table below shows the annual total assets of Imed Infinity Medical-Limited Partnership from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA7.65 Million | -7.33% |
| 2023-12-31 | ILA8.25 Million | -17.64% |
| 2022-12-31 | ILA10.02 Million | -9.42% |
| 2021-12-31 | ILA11.06 Million | -5.67% |
| 2020-12-31 | ILA11.73 Million | -- |